UGT1A1 and neutropenia: Patients with reduced UGT1A1 activity, particularly those homozygous for UGT1A128 (7/7 genotype), are at a significantly higher risk of developing severe (grade 3 or 4) neutropenia compared to those with the 6/6 or 6/7 genotypes [37,38,41].